Common co‐lipids, in synergy, impart high gene transfer properties to transfection‐incompetent cationic lipids
Authors:
- Koushik MukherjeeKMKoushik Mukherjee
- Joyeeta SenJSJoyeeta Sen
- Arabinda ChaudhuriACArabinda Chaudhuri
- 26 January 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (5) , 1291-1300
Abstract
Efficacious cationic transfection lipids usually need either DOPE or cholesterol as co‐lipid to deliver DNA inside the cell cytoplasm in non‐viral gene delivery. If both of these co‐lipids fail in imparting gene transfer properties, the cationic lipids are usually considered to be transfection inefficient. Herein, using both the reporter gene assay in CHO, COS‐1 and HepG2 cells and the whole cell histochemical X‐gal staining assay in representative CHO cells, we demonstrate that common co‐lipids DOPE, Cholesterol and DOPC, when act in synergy, are capable of imparting improved gene transfer properties to a novel series of cationic lipids (1–5). Contrastingly, lipids 1–5 became essentially transfection‐incompetent when used in combination with each of the pure co‐lipid components alone.Keywords
This publication has 38 references indexed in Scilit:
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Recent Developments in Retroviral-Mediated Gene TransductionMolecular Therapy, 2000
- Gene therapy: the first decadeTrends in Biotechnology, 2000
- Cardiovascular gene therapyThe Lancet, 2000
- Virus treatment questioned after gene therapy deathNature, 1999
- A triploblast origin for Myxozoa?Nature, 1998
- Gene therapy - promises, problems and prospectsNature, 1997
- A Controlled Study of Adenoviral-Vector–Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994